Implementation of Stress Ulcer Prophylaxis (SUP) in an Intensive Care Unit (ICU)
Foroud Shahbazi, Hasanali Karimpur, Elham Hosseini
Journal of Pharmaceutical Research International · pp. 1–7 · Published 28 Nov 2019
10.9734/jpri/2019/v31i630326Abstract
Background: Critically ill patients are at high risk for developing stress ulcer bleeding, which may increase the length of hospitalization and mortality rate. Stress ulcer prophylaxis could be done either with PPIs or with H2 receptor blockers, which were prescribed in critically ill patients. Aim: This cross-sectional study was accomplished in an intensive care unit to implement new stress ulcer prophylaxis. Methods: This study was conducted in a tertiary hospital of Kermanshah province, west of Iran. Patients who were hospitalized for at least 72 hours and received SUP prophylaxis, were included in our study. Updated ASHP guideline was used for calculating SUP risk score. Patients received either PPIs or H2RA (intravenously or enteral). Efficacy and safety of early changes to enteral route were evaluated in one year and cost was calculated in three years’ period. Results: This study was conducted on 150 patients with a mean age of 58 ± 18 years old. More than half of patients (53.3%) were male. Stress ulcer prophylaxis was prescribed for all critically ill patients, regardless of the risk of GI bleeding while only 76.6% of patients had an appropriate indication for receiving SUP protocol. Six patients in the PPIs group (4 in intravenous and 2 in enteral) experienced gastrointestinal bleeding. Changing the route of administration from intravenous to intravenous over a three-year period resulted in a decrease in the mean use of pentoprazole vials from 12 to 4 per patient. Conclusion: Early changing (within 72 hours) SUP from IV to enteral is safe and cost-saving approach.
References (11)
- 1 Surviving Sepsis Campaign [DOI]
- 2 Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU [DOI]
- 3 Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients [DOI]
- 4 Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials [DOI]
- 5 Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients [DOI]
- 6 Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis* [DOI]
- 7 Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients [DOI]
- 8 Stress ulcer prophylaxis in hospitalized patients not in intensive care units [DOI]
- 9 Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada [DOI]
- 10 Guideline for stress ulcer prophylaxis in the intensive care unit.
- 11 A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage [DOI]
Cited by 14
Yunus Emre Ayhan, Namigar Turgut · Journal of Pharmacy & Pharmaceutical Sciences · 2025
Yunus Emre Ayhan, Güneş Eskidemir, Ayşe Gül Koçoğlu Kınal · Journal of Pharmacy & Pharmaceutical Sciences · 2025
Joy L Zhao, Christina Tofani, Anthony Infantolino · Cureus · 2024
Naglaa Samir Bazan, Samar Farghali Farid, Darrin Lloyd Baines · Drugs & Therapy Perspectives · 2020
Rodolfo Castro Cesar de OLIVEIRA, Osvaldo MALAFAIA, Fernando Issamu TABUSHI · ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · 2021
Showing 5 of 14 known citations — external sources report more than can currently be individually listed.
Related research
- The Impact of Work and Family Stress on Workers’ Health — shares topic coverage
- Pharmacokinetics and Bioequivalence Study of Two Proton Pump Inhibitor Products — shares topic coverage
- An Evaluation of 605 Endoscopic Examination in a Rural Setting, Lacor Hospital in Northern Uganda — shares topic coverage
- Extraction and Evaluation of the Extract Blend of Carica papaya and Annona muricata as Antiulcerogenic and Gastroprotective Agent — shares topic coverage
- Siddha Diagnostic Methodology of Envagai thervu for Gunmam Patients at Government Siddha Medical College & Hospital, Palayamkottai — shares topic coverage
Article metrics
Real usage data collected on this platform.
49
Page views
0
PDF downloads
6
Outbound clicks
14
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.